A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

Clinical trial NCT01503736 · COMPLETED

Trial details

NCT number: NCT01503736
Sponsor: Panion & BF Biotech Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia End Stage Renal Disease ESRD

Start date: 2010-06-01
Primary completion: 2012-06-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.